<DOC>
	<DOCNO>NCT01211821</DOCNO>
	<brief_summary>The purpose study assess effect BMS-914392 administration pharmacokinetics single-dose metoprolol healthy subject .</brief_summary>
	<brief_title>Effect BMS-914392 Pharmacokinetics Metoprolol</brief_title>
	<detailed_description>Protocol design evaluate potential drug-drug-interaction</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Healthy subject determine clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory determination . Subjects genotyped Intermediate , Extensive Ultrarapid CYP2D6 metabolizers Women childbearing potential ( WOCBP ) men must use acceptable method contraception avoid pregnancy Any significant acute chronic medical illness . Current recent ( within 3 month study drug administration ) gastrointestinal disease . Current history neurological disease psychiatric disorder , cardiovascular disease , bronchospastic disease . CYP2D6 poor metabolizers base genotype</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>